BUB
DGX icon

BBVA USA Bancshares’s Quest Diagnostics DGX Stock Holding History

BBVA USA Bancshares’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,317
Closed -$118K – 524
2019
Q1 		$118K Hold
1,317
– – 0.01% 526
2018
Q4 		$110K Hold
1,317
– – 0.01% 504
2018
Q3 		$142K Buy
+1,317
New +$144K 0.01% 533
2015
Q2 		– Sell
-2,702
Closed -$208K – 510
2015
Q1 		$208K Buy
+2,702
New +$193K 0.01% 532
2013
Q4 		– Sell
-3,298
Closed -$204K – 540
2013
Q3 		$204K Sell
3,298
-2,605
-44% -$156K 0.01% 506
2013
Q2 		$358K Buy
+5,903
New +$352K 0.02% 357

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

BBVA USA Bancshares's DGX Position: Q2 2019 in Review

BBVA USA Bancshares sold out of Quest Diagnostics (DGX) in Q2 2019, closing a stake of 1,317 shares — an estimated $118K sold.

BBVA USA Bancshares first reported a position in DGX in Q2 2013 and held it in 6 quarters. The position peaked at $358K in Q2 2013. 654 funds tracked by Wall St. Rank hold DGX as of Q2 2019.

  • BBVA USA Bancshares reported no remaining Quest Diagnostics position as of Q2 2019 after selling out during the quarter.
  • BBVA USA Bancshares sold 1,317 Quest Diagnostics shares in Q2 2019, an estimated $118K.
  • BBVA USA Bancshares first reported a position in Quest Diagnostics in Q2 2013 and held it in 6 quarters.
  • BBVA USA Bancshares's Quest Diagnostics position peaked at $358K in Q2 2013.
  • 654 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2019.

Based on BBVA USA Bancshares's 13F filing for Q2 2019, filed 5 Aug 2019.